earnings
CH
NASDAQ · CHRS
Coherus Oncology, Inc.
Healthcare · Biotechnology
$1.22
Down-$0.11 (-8.27%)
Updated Sep 17, 2026, 3:12 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 165.18M
- P/E ratio
- 1.07
- Dividend yield
- 0.00%
- 52-week range
- $1.13 – $2.11
- Volume
- 1.29M
- Avg. volume
- 1.23M
Price performance
CHRS price history
1M range · 20 trading sessions · Daily adjusted prices
CHRS closed at $1.22 after 20 trading sessions, down 8.27% for the selected period.
- Last close
- $1.22
- Period change
- -8.27%
- Period low
- $1.22
- Period high
- $1.46
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.34 | $1.35 | $1.21 | $1.22 | 1.29M |
| Sep 15, 2026 | $1.38 | $1.39 | $1.32 | $1.33 | 761.96K |
| Sep 14, 2026 | $1.34 | $1.43 | $1.34 | $1.43 | 1.27M |
| Sep 11, 2026 | $1.378 | $1.38 | $1.325 | $1.33 | 529.19K |
| Sep 10, 2026 | $1.33 | $1.36 | $1.30 | $1.34 | 1.02M |
| Sep 9, 2026 | $1.34 | $1.375 | $1.31 | $1.32 | 840.62K |
| Sep 8, 2026 | $1.40 | $1.43 | $1.36 | $1.37 | 549.2K |
| Sep 4, 2026 | $1.38 | $1.435 | $1.38 | $1.42 | 306.06K |
| Sep 3, 2026 | $1.42 | $1.43 | $1.36 | $1.37 | 437.2K |
| Sep 2, 2026 | $1.37 | $1.435 | $1.355 | $1.42 | 621.49K |
| Sep 1, 2026 | $1.36 | $1.40 | $1.35 | $1.37 | 695.16K |
| Aug 31, 2026 | $1.39 | $1.41 | $1.30 | $1.35 | 1.13M |
| Aug 28, 2026 | $1.45 | $1.48 | $1.40 | $1.41 | 605.09K |
| Aug 27, 2026 | $1.43 | $1.48 | $1.41 | $1.46 | 788.32K |
| Aug 26, 2026 | $1.37 | $1.455 | $1.34 | $1.45 | 896.54K |
| Aug 25, 2026 | $1.36 | $1.4099 | $1.31 | $1.37 | 1.3M |
| Aug 24, 2026 | $1.43 | $1.43 | $1.35 | $1.36 | 1.05M |
| Aug 21, 2026 | $1.32 | $1.44 | $1.315 | $1.42 | 1.57M |
| Aug 20, 2026 | $1.31 | $1.34 | $1.27 | $1.32 | 740.19K |
| Aug 19, 2026 | $1.379 | $1.405 | $1.295 | $1.33 | 3.04M |
Latest CHRS news
The latest Smart Investors Daily articles mentioning CHRS.
Stock researchResearch & News · SEC Filings
Loading stock research…